Precision Peptide Therapeutics. NeuroRelief-P™ | NeuroRegen-P™ | NeuroReset-P™ Patent Pending – PATP1280.03 © Biotech International Institute Patent Pending – PATP1280.03 Research-stage & investigational. No clinical or field-performance claims. NeuroRelief-P™ Peptide innovation for pain modulation, engineered to relieve chronic and neuropathic pain without systemic risks. NeuroRegen-P™ Activates regenerative signaling to drive axonal growth and synaptic repair for injury and degenerative conditions. NeuroReset-P™ Stabilizes neural circuits and supports recovery from substance dependency through structural and biochemical rebalancing. Patent Pending – PATP1280.03 Neuroscience R&D researching mechanism-first platform developments across neural recovery biology, scaffold innovation, and neuroresilience pathways. Research-stage & investigational. No clinical or field-performance claims. NeuroReset™ Neural recovery biology platform exploring measurable circuit-state stabilization after prolonged dysregulation.Neurophorol™ Cannabinoid-inspired scaffold innovation (xanthene direction) designed for systematic profiling and endpoint mapping.Mycophorol™ Fungal-inspired neuroresilience platform designed for biomarker and metabolomics-driven evaluation.
